Moneycontrol PRO
Open App
Upcoming Event : Traders Conclave 2022 | India's Largest Retail Stock Investors & Traders Residential Conclave
you are here: HomeNewsIndia

Second dose COVID-19 vaccine for 100% adult population in Himachal Pradesh by next week

Himachal Pradesh is close to administering the second dose of its vaccination to 90 per cent of the population as on date, he told PTI.

November 25, 2021 / 02:34 PM IST
File image of ZyCov-D vaccine (Source: Twitter)

File image of ZyCov-D vaccine (Source: Twitter)

Himachal Pradesh is likely to vaccinate 100 per cent of its eligible adult population with the second dose of the COVID-19 vaccine by next week, state Health Secretary Amitabh Avasthi said on Thursday.

Himachal Pradesh is close to administering the second dose of its vaccination to 90 per cent of the population as on date, he told PTI.

"We have set up a target for ourselves to accomplish complete saturation of vaccination in the next seven days," he said.

Union Health Minister Mansukh Mandaviya is likely to visit Bilaspur to participate in a function in this regard on December five, he added.

During interaction with healthcare workers and beneficiaries of the vaccination programme via video conferencing in September, Prime Minister Narendra Modi had lauded Himachal Pradesh’s efforts to complete the first dose of vaccination of 100 per cent adult population in the state.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Himachal Pradesh became the first state three months ago to achieve 100 per cent first-dose vaccination of eligible adult population.
first published: Nov 25, 2021 02:36 pm
ISO 27001 - BSI Assurance Mark